Cargando…
Narrative review based on fingolimod therapy in pediatric MS
The course of pediatric-onset multiple sclerosis and adult multiple sclerosis shows some clinical differences. The rate of having a second attack after the first clinical event is 80% in children and around 45% in adults but the time to the second event is similar in all age groups. The pediatric gr...
Autores principales: | Piri Cinar, Bilge, Konuskan, Bahadır, Anlar, Banu, Ozakbas, Serkan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170592/ https://www.ncbi.nlm.nih.gov/pubmed/37181277 http://dx.doi.org/10.1177/20503121231171996 |
Ejemplares similares
-
The Turkish validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) battery
por: Ozakbas, Serkan, et al.
Publicado: (2017) -
Synthetic MRI in children with tuberous sclerosis complex
por: Coban, Gokcen, et al.
Publicado: (2022) -
A combination of Q-TOF LC/MS and LC-MS/MS based metabolomics in pediatric-onset multiple sclerosis demonstrates potential biomarkers for unclassified patients
por: SOLMAZ, İsmail, et al.
Publicado: (2022) -
A Preliminary Study on the Meaning of Inflammatory Indexes in MS: A Neda-Based Approach
por: Bunul, Sena Destan, et al.
Publicado: (2023) -
Triggers and clinical changes of childhood primary headache characteristics during COVID-19 pandemic lockdown
por: Dedeoglu, Özge, et al.
Publicado: (2022)